The stock ended flat at Rs 410 and clocked volumes of 201,186 shares at the counter on the BSE. __________________________________
(Updated at 1128hrs)
Ranbaxy Laboratories has advanced after the World Health Organization included its Indinavir capsules to treat HIV/Aids in its pre-qualification list.
The stock opened at Rs 411 and soared to a high of Rs 419, up around 2% from the previous close. The stock is now marginally at Rs 414. The counter has clocked volumes of 65,997 shares as compared to the two-week daily average traded volumes of 414,369 shares on the BSE.
Click here to read more: Ranbaxy gains WHO pre-qualification for Indinavir - 400mg ARV capsules
